• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管加压素/催产素受体家族中激动剂选择性的分子基础。

Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.

作者信息

Chini B, Mouillac B, Ala Y, Balestre M N, Cotte N, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M

机构信息

Unité INSERM 401, CCIPE, Montpellier, France.

出版信息

Adv Exp Med Biol. 1995;395:321-8.

PMID:8713982
Abstract

Vasopressin (AVP) and oxytocin (OT) are two nonapeptides differing at position 3, in the cyclic part of the peptide, and at position 8, in the C-terminal tripeptide. In this study, we have evaluated the interactions between these two positions of the hormones and the oxytocin receptor (OTR), the V1a and the V2 vasopressin receptors. The contribution of these two positions to receptor selectivity was analyzed by using several peptide analogues bearing substitutions at either position 3 or 8. The putative interactions between receptor residues and hormone residues at position 3 and 8 were then deduced by using a three dimensional model of the neurohypophysial hormones docked into their respective receptors. On the basis of this model, we found that the lateral chain of residue 8 might interact with residues located in the first extracellular loop. By using site-directed mutagenesis on the cloned receptors, we identified a non-conserved residue in the first extracellular loop that interacts with the lateral chain of residue 8 in the hormone. We demonstrated that this interaction is crucial for receptor selectivity to the different agonists.

摘要

血管加压素(AVP)和催产素(OT)是两种九肽,在肽的环状部分的第3位以及C端三肽的第8位存在差异。在本研究中,我们评估了激素这两个位置与催产素受体(OTR)、V1a和V2血管加压素受体之间的相互作用。通过使用在第3位或第8位带有取代基的几种肽类似物,分析了这两个位置对受体选择性的贡献。然后,通过将神经垂体激素对接至各自受体的三维模型,推断受体残基与第3位和第8位激素残基之间的假定相互作用。基于该模型,我们发现第8位残基的侧链可能与位于第一个细胞外环中的残基相互作用。通过对克隆受体进行定点诱变,我们在第一个细胞外环中鉴定出一个与激素中第8位残基的侧链相互作用的非保守残基。我们证明这种相互作用对于受体对不同激动剂的选择性至关重要。

相似文献

1
Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.血管加压素/催产素受体家族中激动剂选择性的分子基础。
Adv Exp Med Biol. 1995;395:321-8.
2
Identification of agonist binding sites of vasopressin and oxytocin receptors.
Adv Exp Med Biol. 1995;395:301-10.
3
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.酪氨酸115是决定血管加压素V1a受体激动剂选择性的关键残基。
EMBO J. 1995 May 15;14(10):2176-82. doi: 10.1002/j.1460-2075.1995.tb07211.x.
4
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.血管加压素和催产素V1a、V1b、V2及OT受体的肽类和非肽类激动剂与拮抗剂:研究工具及潜在治疗药物
Prog Brain Res. 2008;170:473-512. doi: 10.1016/S0079-6123(08)00437-8.
5
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions.神经肽血管加压素V1a受体的结合位点。跨膜区域内主要定位的证据。
J Biol Chem. 1995 Oct 27;270(43):25771-7. doi: 10.1074/jbc.270.43.25771.
6
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin.两个芳香族残基调节人类催产素受体对部分激动剂精氨酸加压素的反应。
FEBS Lett. 1996 Nov 18;397(2-3):201-6. doi: 10.1016/s0014-5793(96)01135-0.
7
Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.鉴定参与配体结合和G蛋白偶联的神经垂体激素受体结构域。
Adv Exp Med Biol. 1998;449:371-85. doi: 10.1007/978-1-4615-4871-3_48.
8
Molecular pharmacology of human vasopressin receptors.人类血管加压素受体的分子药理学
Adv Exp Med Biol. 1998;449:251-76. doi: 10.1007/978-1-4615-4871-3_34.
9
Functional architecture of vasopressin/oxytocin receptors.血管加压素/催产素受体的功能结构
J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):589-96. doi: 10.3109/10799899909036674.
10
Critical role of a subdomain of the N-terminus of the V1a vasopressin receptor for binding agonists but not antagonists; functional rescue by the oxytocin receptor N-terminus.血管升压素V1a受体N端一个亚结构域在结合激动剂而非拮抗剂方面的关键作用;催产素受体N端的功能拯救。
Biochemistry. 2000 Nov 7;39(44):13524-33. doi: 10.1021/bi0013400.

引用本文的文献

1
Expanding the versatility and scope of the oxime ligation: rapid bioconjugation to disulfide-rich peptides.拓展肟连接的多功能性和应用范围:快速生物偶联到富含二硫键的肽。
Chem Commun (Camb). 2022 Aug 11;58(65):9100-9103. doi: 10.1039/d2cc03752a.
2
Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists.雄性生殖管道中的催产素;催产素激动剂和拮抗剂的治疗潜力。
Front Endocrinol (Lausanne). 2020 Oct 22;11:565731. doi: 10.3389/fendo.2020.565731. eCollection 2020.
3
Oxytocin Receptor Signaling in Vascular Function and Stroke.
血管功能与中风中的催产素受体信号传导
Front Neurosci. 2020 Sep 25;14:574499. doi: 10.3389/fnins.2020.574499. eCollection 2020.
4
Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes.功能性选择性催产素衍生激动剂可区分个体 G 蛋白家族亚型。
J Biol Chem. 2012 Feb 3;287(6):3617-29. doi: 10.1074/jbc.M111.277178. Epub 2011 Nov 8.
5
Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue.
Br J Cancer. 2003 Sep 1;89(5):930-6. doi: 10.1038/sj.bjc.6601189.